Literature DB >> 3742157

Influence of the optical isomers (+)- and (-)-naloxone on beating frequency, contractile force and action potentials of guinea-pig isolated cardiac preparations.

H Brasch.   

Abstract

Naloxone in concentrations ranging from 7.5 to 120 mumol l-1 reduced the beating frequency of guinea-pig isolated atria. The ED50 was 7.9 mumol l-1 for the (-)-isomer and 10.8 mumol l-1 for the (+)-isomer. Concentrations up to 120 mumol l-1 of either (-)- or (+)-naloxone did not affect the force of contraction of left atria stimulated at 1 Hz. In concentrations from 30 to 120 mumol l-1 (-)-naloxone increased the action potential (AP) duration and the functional refractory period (FRP) of papillary muscles. The resting membrane potential and the AP amplitude remained unchanged, while a small decrease of Vmax was seen with the larger drug concentrations. The influence of (+)-naloxone (120 mumol l-1) was comparable to that of the (-)-isomer. The influence of morphine (120 mumol l-1) on papillary muscle AP was small. AP duration and FRP showed a marginal prolongation while Vmax was slightly decreased. (-)-Naloxone 60 mumol l-1 had no effect on slow-response APs of K+-depolarized papillary muscles. Slow-response APs were abolished by verapamil (1 mumol l-1). In left atrial strips the prolongation of the AP duration produced by 120 mumol l-1 of either (-)- or (+)-naloxone resembled the drug effect in papillary muscles. Most of the observed changes can be explained by an inhibition of the time-dependent membrane K+ outward current, an effect of naloxone that may be classified as a Class III antiarrhythmic action. Apparently this effect is not mediated by stereospecific opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742157      PMCID: PMC1917083          DOI: 10.1111/j.1476-5381.1986.tb16245.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Opiate antagonist reverses the cardiovascular effects of inhalation anaesthesia.

Authors:  J O Arndt; E Freye
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

2.  Reconstruction of the action potential of ventricular myocardial fibres.

Authors:  G W Beeler; H Reuter
Journal:  J Physiol       Date:  1977-06       Impact factor: 5.182

Review 3.  Electrophysiological basis for a rational approach to antidysrhythmic drug therapy.

Authors:  E M Williams
Journal:  Adv Drug Res       Date:  1974

4.  Nature of the morphine receptor present in the squid axon.

Authors:  D T Frazier; M Ohta; T Narahashi
Journal:  Proc Soc Exp Biol Med       Date:  1973-04

5.  Failure of peptides (angiotensin, bradykinin, substance P, physalaemin, Met-enkephalin) to influence the cardiac action potential.

Authors:  H Iven; G Zetler
Journal:  Pharmacology       Date:  1980       Impact factor: 2.547

6.  Failure of (+)-naloxone to antagonise responses to opioid peptides.

Authors:  R J Gayton; L A Lambert; P B Bradley
Journal:  Neuropharmacology       Date:  1978-07       Impact factor: 5.250

7.  Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action.

Authors:  S H Ngai; B A Berkowitz; J C Yang; J Hempstead; S Spector
Journal:  Anesthesiology       Date:  1976-05       Impact factor: 7.892

8.  Pharmacokinetics of naloxone and naltrexone in the dog.

Authors:  N L Pace; R G Parrish; M M Lieberman; K C Wong; R A Blatnick
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

9.  Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: evidence for sympathomedullary involvement.

Authors:  J W Holaday; R J D'Amato; B A Ruvio; G Feuerstein; A I Faden
Journal:  Circ Shock       Date:  1983

10.  Effects of the local anesthetics brufacain and lidocaine on transmembrane action potentials, refractory period, and reactivation of the sodium system in guinea pig heart muscle.

Authors:  H Iven; H Brasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

View more
  8 in total

1.  The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia.

Authors:  R Sitsapesan; J R Parratt
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

2.  Failure to reproduce the in vitro cardiac electrophysiological effects of naloxone in humans.

Authors:  K G Oldroyd; A C Rankin; C E Gray; K Harvey; W Borland; A P Rae; S M Cobbe
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

3.  Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity.

Authors:  N Chatterjie; G J Alexander; J A Sechzer; K W Lieberman
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

4.  The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.

Authors:  G Boachie-Ansah; R Sitsapesan; K A Kane; J R Parratt
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

5.  Stereospecific antiarrhythmic effects of naloxone against myocardial ischaemia and reperfusion in the dog.

Authors:  A Y Lee
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

6.  Beta endorphin release in patients after spontaneous and provoked acute myocardial ischaemia.

Authors:  K G Oldroyd; K Harvey; C E Gray; G H Beastall; S M Cobbe
Journal:  Br Heart J       Date:  1992-03

7.  Anti-arrhythmic activities of opioid agonists and antagonists and their stereoisomers.

Authors:  Y Sarne; A Flitstein; E Oppenheimer
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

8.  Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.

Authors:  Phu N Tran; Jiansong Sheng; Aaron L Randolph; Claudia Alvarez Baron; Nicolas Thiebaud; Ming Ren; Min Wu; Lars Johannesen; Donna A Volpe; Dakshesh Patel; Ksenia Blinova; David G Strauss; Wendy W Wu
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.